The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 328.50
Ask: 330.50
Change: -7.50 (-2.24%)
Spread: 2.00 (0.609%)
Open: 329.00
High: 332.50
Low: 321.00
Prev. Close: 334.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Citigroup cuts Wizz Air to 'sell'

Wed, 18th Oct 2023 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

Deutsche Bank raises InterContinental Hotels target to 5,800 (5,390)p - 'hold'

----------

Citigroup cuts IAG price target to 175 (195) pence - 'buy'

----------

RBC cuts Diageo price target to 3,000 (3,100) pence - 'underperform'

----------

RBC raises Rio Tinto price target to 5,100 (4,800) pence - 'sector perform'

----------

JPMorgan cuts Rio Tinto price target to 6,170 (6,200) pence - 'neutral'

----------

Bank of America cuts Burberry price target to 1,900 (2,000) pence - 'underperform'

----------

FTSE 250

----------

Stifel cuts Watches of Switzerland price target to 590 (680) pence - 'hold'

----------

Bank of America cuts Watches of Switzerland price target to 600 (650) pence - 'neutral'

----------

Citigroup cuts Wizz Air to 'sell' (neutral) - price target 1,400 (3,100) pence

----------

Barclays cuts Jupiter Fund Management price target to 105 (130) pence - 'equal weight'

----------

JPMorgan cuts Bellway price target to 2,170 (2,300) pence - 'overweight'

----------

RBC cuts Bellway price target to 3,400 (3,500) pence - 'outperform'

----------

RBC raises Moneysupermarket.com price target to 310 (300) pence - 'outperform'

----------

Jefferies cuts IntegraFin price target to 235 (280) pence - 'hold'

----------

SMALL CAP

----------

Citigroup raises Ryanair price target to 22 (21.50) EUR - 'buy'

----------

RBC cuts Oxford BioMedica price target to 720 (1,010) pence - 'outperform'

----------

JPMorgan raises Tullow Oil price target to 60 (55) pence - 'overweight'

----------

JPMorgan raises EnQuest price target to 30 (27) pence - 'overweight'

----------

RBC cuts Central Asia Metals price target to 200 (240) pence - 'outperform'

----------

RBC cuts Ecora Resources price target to 160 (190) pence - 'outperform'

----------

RBC raises Adriatic Metals price target to 340 (320) pence - 'outperform'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more
30 Oct 2020 08:47

Oxford Biomedica partner delays Parkinson's disease treatment trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.

Read more
23 Oct 2020 15:15

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

Read more
6 Oct 2020 14:19

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Read more
6 Oct 2020 09:44

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Read more
6 Oct 2020 07:55

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

Read more
6 Oct 2020 07:43

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

Read more
6 Oct 2020 07:03

Oxford Biomedica new manufacturing suite approved

(Sharecast News) - Oxford Biomedica said it had received government approval for a fourth manufacturing suite within its Oxbox facility which will be used to develop a potential Covid-19 vaccine.

Read more
17 Sep 2020 10:43

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Read more
17 Sep 2020 08:35

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

Read more
17 Sep 2020 07:52

LONDON MARKET PRE-OPEN: Next Raises Full-Year Profit Outlook

LONDON MARKET PRE-OPEN: Next Raises Full-Year Profit Outlook

Read more
17 Sep 2020 07:01

Oxford Biomedica sees swing to FY profit on Covid vaccine hopes

(Sharecast News) - Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.